In in vivo and in vitro ICH models, fractalkine located in neuronal cells can interact with the unique fractalkine receptor CX3CR1 and promote hematoma absorption through the PPAR-γ/CD163/HO-1 signaling pathway. The gene discussed is CD163; the disease is hematoma.